About Kevin Hodgetts
Kevin Hodgetts is a promoter at Modulate Bio.
Kevin Hodgetts first appears on SEC filings in 2024.
Experience
This experience comes from Kevin Hodgetts's profile and from SEC filings. For roles taken from filings, the years are when the filings name Kevin Hodgetts in the role, so the role may have started earlier or lasted longer.
Modulate Bio Inc. Current
Co-Founder
2024 – Present · Allston, MA
Develops medicines for people with neurological disorders, including essential tremor and epilepsy.
HS
Harvard Medical School Current
Associate Professor of Neurology
2015 – Present
BH
Brigham and Women's Hospital Current
Head of Medicinal Chemistry and Director of the Lab for Drug Discovery in Neuroscience
2012 – Present
VT
Violet Therapeutics
Co-Founder
2021 – 2022
GA
Galenea
Senior Scientist and Co-Project Leader
2008 – 2011
NC
Neurogen Corporation
Senior Research Fellow and Project Leader
1998 – 2008
Key Colleagues at Startups
The people Kevin Hodgetts works with at each company, as listed on that company's latest Form D.
Modulate Bio Inc. · Form D/A, Apr 7, 2026
DD
Dario Doller
Executive officer, director and promoter
AT
Andrew Thomson
President and director